At Tampa General Hospital, we are committed to fostering continuous learning and collaboration among health care professionals. TGH Grand Rounds lectures bring together leading experts to share the latest advancements, research, and clinical insights across multiple specialties. Explore Grand Rounds recordings and other resources from our Institutes below to stay informed and enhance patient care.
Cancer Institute Grand Rounds
Our Cancer Institute Grand Rounds provide a platform for oncology professionals to learn about cutting-edge therapies, clinical trials, and multidisciplinary approaches to cancer care. Explore these sessions to gain valuable insights into the latest strategies for diagnosis, treatment, and patient support.
CME credits can only be claimed within four days of the activity. These lectures fall outside that timeframe and are therefore ineligible for CME credits.
Presented By:
Monica Fornier, MD
Associate Member, Breast Medicine Service Memorial Sloan Kettering Cancer Center
Associate Professor Weill Cornell Medical College
Objectives:
- Review current data on the role of bone-modifying agents for both early stage and metastatic breast carcinoma patients.
- Discuss ongoing research with novel agents and pathways currently being investigated.
- At the end of the lecture, the audience will be familiar with data and optimal use of bone-modifying agents for patients with breast carcinoma, and also have knowledge of latest research avenues in this setting.
Presented By:
Kate Lally, MD, FAAHPM
Clinical Director, Adult Palliative Care
Department of Supportive Oncology, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Erin Solomon, LICSW
Senior Clinical Social Worker
Supportive Oncology Collaborative (SOC)
Dana-Farber Cancer Institute
Carrie C. Wu, MD
Clinical Director of Collaborative Care and Satellites, Adult Psychosocial Oncology
Department of Supportive Oncology, Dana-Farber Cancer Institute
Instructor of Psychiatry, Harvard Medical School
Objectives:
- Identify the four key components of collaborative care.
- Explain how a collaborative care model increases access to care.
- Illustrate the application of a collaborative care model through a patient case example.
Presented By:
Allyson J. Ocean, M.D.
Professor of Clinical Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Medical Director, Pancreatic Cancer Clinical Research Program
Director, Early Onset Gastrointestinal Cancer Program
Objectives:
- Explore the data for ctDNA testing in GI cancers.
- Explore using ctDNA for decision-making in GI cancers.
- Presentation of case studies.
Presented By:
Jaydira Del Rivero, MD
Associate Research Physician, Developmental Therapeutics Branch
National Cancer Institute
National Institutes of Health
Objectives:
- Understanding targeted therapeutic agents for thyroid and neuroendocrine cancers.
- Discuss clinical outcomes such as response rates, progression-free survival, and overall survival comparisons.
- Highlight advancements.
Heart & Vascular Institute (HVI) Grand Rounds
Stay at the forefront of cardiovascular medicine with Grand Rounds from the TGH Heart & Vascular Institute. These sessions feature expert discussions on innovative treatments, surgical techniques, and emerging research in heart and vascular care. Access recordings and resources to deepen your expertise and improve outcomes for your patients.
Presented By Vikram Kashyap, MD
Click the link below to access the accredited education:
https://cmetracker.net/USF/Publisher?page=pubOpen#/EventID/363070/qr
Learning Objectives:
- Recognize different models for cardiovascular care
- Analyze healthcare trends affecting providers and institutions
- Discuss the benefits of an institute-based organizational structure
Accreditations:
Physicians
ACCME: USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Florida Board of Medicine: USF Health is an approved provider of continuing education for physicians through the Florida Board of Medicine. This activity has been reviewed and approved for .50 continuing education credit.
Florida Board of Osteopathic Medicine: USF Health is an approved provider of continuing education for physicians through the Florida Board of Osteopathic Medicine. This activity has been reviewed and approved for up to .50 continuing education credit.
Physician Assistant: Florida Physician Assistant Continuing Education Credit: USF Health is an approved provider (50-2970) of Florida Physician Assistant continuing education credit through the Florida Board of Medicine. This activity has been approved for .50 continuing education credit.
Target Audience: This activity was designed to meet the educational needs of physicians, physician assistants, and nurses.
Release Date: 11/12/25
Expiration Date: 11/11/26
Relevant Financial Relationships:
All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
- Paul Forfia, MD – Advisory Board: United Therapeutics, Merck, Jansson
- Daniel Lenihan, MD – Consultant: AstraZeneca, Intellia, Myocardial Solutions, Clementia; Speaker: BridgeBio
- Benjamin Mackie, MD – Speakers Bureau: Care DX, Thermofischer
- Erick Yang, MD – Consultant: Edwards Lifesciences, Xencor; Grants: Amgen, Bristol Myers Squibb, Janssen; Speaker Fees: Zoll Medical
- Christopher Zarins, MD – Employee and Stockholder: HeartFlow
Disclaimer: The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options for a specific patient’s medical condition.
Questions
If you have continuing education questions, please contact USF Health at cpdsupport@usf.edu.
Presented By Christopher Zarins, MD
Click the link below to access the accredited education:
https://cmetracker.net/USF/Publisher?page=pubOpen#/EventID/363033/qr
Learning Objectives:
- Identify three markers of coronary disease in PAD patients who have no chest pain symptoms.
- Justify why they recommend or order a coronary CT scan for their PAD patient.
- Develop a plan for managing coexisting CAD based on non-invasive diagnosis of CAD in PAD patients.
- Differentiate between high-risk ischemia-causing coronary lesions and low-risk non-obstructive coronary lesions in patients with carotid and peripheral artery disease.
Accreditations:
Physicians
ACCME: USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Florida Board of Medicine: USF Health is an approved provider of continuing education for physicians through the Florida Board of Medicine. This activity has been reviewed and approved for 1.00 continuing education credit.
Florida Board of Osteopathic Medicine: USF Health is an approved provider of continuing education for physicians through the Florida Board of Osteopathic Medicine. This activity has been reviewed and approved for up to 1.00 continuing education credit.
Physician Assistant: USF Health is an approved provider (50-2970) of Florida Physician Assistant continuing education credit through the Florida Board of Medicine. This activity has been approved for 1.00 continuing education credit.
Nursing: USF Health (provider number 2970) is an approved provider of continuing education for nurses through the Florida Board of Nursing. This activity has been approved for 1.00 contact hour.
Target Audience: This activity was designed to meet the educational needs of physicians, physician assistants, and nurses.
Release Date: 10/31/25
Expiration Date: 10/30/26
Relevant Financial Relationships:
All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
- Benjamin Mackie, MD – Speakers Bureau: Care DX, Thermofischer
- Christopher Zarins, MD – Employee and Stockholder: HeartFlow
Disclaimer: The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options for a specific patient’s medical condition.
Questions
If you have continuing education questions, please contact USF Health at cpdsupport@usf.edu.
Presented by James De-Lemons, MD
Chief of Cardiology
Professor, Department of Internal Medicine
Associate Director, Cardiovascular Fellowship Program
UT Southwestern Medical Center
Click the link below to access the accredited education:
https://cmetracker.net/USF/Publisher?page=pubOpen#/EventID/363122/qr
Learning Objectives:
- Identify the strengths and limitations of currently available cardiovascular risk assessment approaches.
- Recognize biomarkers for risk assessment and therapeutic guidance in cardiovascular prevention.
- Discuss the appropriate use of actuarial risk assessment for specific cardiovascular outcomes to help guide decisions for CVD prevention and treatment.
- Describe how to incorporate risk assessment to enhance population health efforts regarding cardiovascular prevention.
Accreditations:
Physicians
ACCME: USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Florida Board of Medicine: USF Health is an approved provider of continuing education for physicians through the Florida Board of Medicine. This activity has been reviewed and approved for 1.00 continuing education credit.
Florida Board of Osteopathic Medicine: USF Health is an approved provider of continuing education for physicians through the Florida Board of Osteopathic Medicine. This activity has been reviewed and approved for up to 1.00 continuing education credit.
Physician Assistant: Florida Physician Assistant Continuing Education Credit: USF Health is an approved provider (50-2970) of Florida Physician Assistant continuing education credit through the Florida Board of Medicine. This activity has been approved for 1.00 continuing education credit.
Nurses
ANCC Accreditation Statement: USF Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Nurses who complete this NCPD activity and claim credit can be awarded up to 1.00 ANCC contact hours.
USF Health is currently providing ANCC credit for all nursing-related activities. The ANCC is a premier national accrediting organization whose credits meet nursing licensure requirements in all states and satisfy applicable nurse credentialing CE requirements.
When you claim ANCC credit, please keep your certificates or transcripts for your records and upload them to your CE Broker account before the end of your license year. USF Health cannot upload ANCC certificates to CE Broker on your behalf.
Target Audience: This activity was designed to meet the educational needs of physicians, physician assistants, and nurses.
Release Date: 11/21/25
Expiration Date: 11/20/26
Relevant Financial Relationships:
All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
- Paul Forfia, MD – Advisory Board: United Therapeutics, Merck, Jansson
- Daniel Lenihan, MD – Consultant: AstraZeneca, Intellia, Myocardial Solutions, Clementia; Speaker: BridgeBio
- Benjamin Mackie, MD – Speakers Bureau: Care DX, Thermofischer
- Erick Yang, MD – Consultant: Edwards Lifesciences, Xencor; Grants: Amgen, Bristol Myers Squibb, Janssen; Speaker Fees: Zoll Medical
- Christopher Zarins, MD – Employee and Stockholder: HeartFlow
- James De-Lemons, MD – Advisory Board: DSMB for Novo Nordisk, Eli Lilly (relationship ended), Merck, Amgen, Regeneron, Verve Therapeutics
Disclaimer: The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options for a specific patient’s medical condition.
Questions: If you have continuing education questions, please contact USF Health at cpdsupport@usf.edu.